These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios. Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900 [TBL] [Abstract][Full Text] [Related]
3. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro. Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214 [TBL] [Abstract][Full Text] [Related]
4. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome. Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309 [TBL] [Abstract][Full Text] [Related]
5. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. Fox RI; Kang HI; Ando D; Abrams J; Pisa E J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070 [TBL] [Abstract][Full Text] [Related]
6. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Boumba D; Skopouli FN; Moutsopoulos HM Br J Rheumatol; 1995 Apr; 34(4):326-33. PubMed ID: 7788146 [TBL] [Abstract][Full Text] [Related]
7. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175 [TBL] [Abstract][Full Text] [Related]
8. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome. Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950 [TBL] [Abstract][Full Text] [Related]
9. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome. Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244 [TBL] [Abstract][Full Text] [Related]
10. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca. Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719 [TBL] [Abstract][Full Text] [Related]
11. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome. Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207 [TBL] [Abstract][Full Text] [Related]
12. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association. Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome. Kim SK; Choe JY; Lee GH Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771 [TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis. Zhang LW; Zhou PR; Wei P; Cong X; Wu LL; Hua H Scand J Immunol; 2018 Apr; 87(4):e12649. PubMed ID: 29476557 [TBL] [Abstract][Full Text] [Related]
15. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome. Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203 [TBL] [Abstract][Full Text] [Related]
16. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells. Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953 [TBL] [Abstract][Full Text] [Related]
17. Exploring the relationship between oxidative stress status and inflammatory markers during primary Sjögren's syndrome: A new approach for patient monitoring. Benchabane S; Sour S; Zidi S; Hadjimi Z; Nabila L; Acheli D; Bouzenad A; Belguendouz H; Touil-Boukoffa C Int J Immunopathol Pharmacol; 2024; 38():3946320241263034. PubMed ID: 38901876 [TBL] [Abstract][Full Text] [Related]
18. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome. Guggino G; Rizzo C; Mohammadnezhad L; Lo Pizzo M; Lentini VL; Di Liberto D; La Barbera L; Raimondo S; Shekarkar Azgomi M; Urzì O; Berardicurti O; Campisi G; Alessandro R; Giacomelli R; Dieli F; Ciccia F RMD Open; 2023 May; 9(2):. PubMed ID: 37137540 [TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking in primary Sjögren's syndrome: positive association only with ANA positivity. Karabulut G; Kitapcioglu G; Inal V; Kalfa M; Yargucu F; Keser G; Emmungil H; Gokmen NM; Kocanaogullari H; Aksu K Mod Rheumatol; 2011 Dec; 21(6):602-7. PubMed ID: 21445716 [TBL] [Abstract][Full Text] [Related]